Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists track families with rare gene to unlock blood cancer mysteries

NCT ID NCT07019155

First seen Nov 20, 2025 · Last updated May 23, 2026 · Updated 25 times

Summary

This study follows people with inherited gene changes (DDX41) that raise the risk of blood cancers like MDS and AML. Researchers will track health over 10 years using exams, blood tests, and optional bone marrow biopsies. No treatment is given; the goal is to understand how these gene changes lead to cancer. Participants include anyone aged 1 month or older with the gene change and their relatives.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.